EU anti-counterfeiting law approved, but much work still to be done
This article was originally published in Scrip
Executive Summary
The European Parliament has finally approved the directive on tackling the trade in counterfeit medicines, after several months of discussions with the Council of Ministers over the final shape of the legislation. Stakeholders including the pharmaceutical industry and wholesalers have broadly welcomed the vote, albeit with some reservations on issues such as product pack verification.